
ProHance 279.3 mg/mL Injection, 10 mL Single-Dose Vial, 5 Vials/Pack
- UPC
- 30302701111018
- Manufacturer:
- BRACCO DIAGNOSTICS, INC.
- Form
- VIAL
- Unit size
- 5X10ML
- Strength
- 279.3MG/ML
Details
Details
ProHance — 279.3MG/ML, Solution for injection, box of 5 × 10 mL vials
ProHance (gadoteridol) is a solution for injection for intravenous use. ProHance is a gadolinium-based contrast agent indicated for magnetic resonance imaging (MRI) to visualize: lesions with disrupted blood brain barrier and/or abnormal vascularity in the brain (intracranial lesions), spine and associated tissues in adults and pediatric patients, including term neonates ( 1.1 ) lesions in the head and neck in adults ( 1.2 ) 1.1 MRI of the Central Nervous System (CNS) ProHance is indicated for magnetic resonance imaging (MRI) in adults and pediatric patients including term neonates to visualize lesions with disrupted blood brain barrier and/or abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. 1.2 MRI of Extracranial/Extraspinal Head and Neck ProHance is indicated for MRI in adults to visualize lesions in the head and neck.
- Active ingredient or product type: gadoteridol
- Strength/concentration: 279.3MG/ML
- Dosage form and route: Solution for injection, Intravenous
- Exact package presentation: box of 5 × 10 mL vials
- NDC/item number: 0270-1111-01
- Manufacturer: BRACCO DIAGNOSTICS, INC.
- Storage/handling: Store at 25°C (77° F). Protect from light. DO NOT FREEZE.
- Status: Rx only
Important safety information: Hypersensitivity: anaphylactic/anaphylactoid reactions with cardiovascular, respiratory and cutaneous manifestations, ranging from mild to severe reactions including shock can occur.
Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.